Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing biologics…
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis Evommune, Inc. a clinical-stage biotechnology company developing innovative therapies that target key drivers of…
AlphaLab Selects 20 Startups for 2026 Cohort Embedding Intelligence Into Industry AlphaLab, the accelerator of Innovation Works helping entrepreneurs accelerate their path to market, has selected 20 companies to join its 2026…
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science…
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board bioAffinity Technologies, Inc. a biotechnology company focused on noninvasive diagnostics and early cancer detection,…
Galux Raises $29M Series B to Advance AI-Driven Protein Design for Drug Discovery Galux, a South Korea-based biotech pioneering AI-driven protein therapeutics design, today announced the successful completion of a…
Kradle Expands Feline Supplement Portfolio With Kradle Max Full-Spectrum Hemp Calming Tincture for Cats Kradle, a premium pet wellness brand known for its innovative and easy-to-use natural calming solutions for…
Keepit Receives 2025 Backup and Disaster Recovery Award from Cloud Computing Magazine Keepit, the only independent, cloud-native data protection and recovery provider, today announced that TMC, a global, integrated media company,…
The Global Mobile Medical Association Launches to Transform Community Healthcare with Unified Network The Global Mobile Medical Association (GMMA), the world’s first comprehensive network dedicated to advancing the mobile healthcare…
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics, a leader in vectorized antibody therapies for…
Ethris and German Center for Infection Research (DZIF) Announce Strategic Collaboration to Develop mRNA-Based Vaccines Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center…
Tend Health and SafeHavenMD Announce Strategic Partnership to Expand Confidential Mental Health Care for Physicians Tend Health and SafeHavenMD today announced a strategic partnership to expand access to confidential, high-quality mental health care…